Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

INTRODUCTION: Extended adjuvant endocrine therapy for breast cancer with aromatase inhibitors may potentially alter the lipid profile of postmenopausal patients and thus increase the risk of developing cardiovascular disease. In this study, a subprotocol of the ATENA (Adjuvant post-Tamoxifen Exemest...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Markopoulos, Christos, Dafni, Urania, Misitzis, John, Zobolas, Vasilios, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Xepapadakis, Grigorios, Papadiamantis, John, Venizelos, Basileios, Antonopoulou, Zoh, Gogas, Helen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716503/
https://ncbi.nlm.nih.gov/pubmed/19531217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2320
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky